Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -155582.08% is 4291% below its 5-year average of -3543.07%, near the low end of its 5-year range (-696857.22%–1208456.74%).
1273.25% below its 12-month average of -11329.47%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-155582.08%
NET PROFIT MARGIN AVG TTM
-11329.47%
NET PROFIT MARGIN AVG 3Y
-10979.33%
NET PROFIT MARGIN AVG 5Y
-3543.07%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1273.25%
CURRENT VS 3Y AVG
-1317.04%
CURRENT VS 5Y AVG
-4291.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-59839161.54%
vs the sector median at left
InflaRx N.V.
Market Cap
$232.50M
Net Profit Margin
-155582.08%
TTM Avg
-11329.47%
3Y Avg
-10979.33%
5Y Avg
-3543.07%
Market Cap
$233.28M
Net Profit Margin
-8.70%
TTM Avg
-47.52%
3Y Avg
-47.68%
5Y Avg
-98.44%
Market Cap
$233.62M
Net Profit Margin
-912.25%
TTM Avg
-448.06%
3Y Avg
-224.03%
5Y Avg
-224.03%
Market Cap
$234.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$234.90M
Net Profit Margin
-5.14%
TTM Avg
33.66%
3Y Avg
36.64%
5Y Avg
40.60%
Market Cap
$234.98M
Net Profit Margin
29.04%
TTM Avg
31.61%
3Y Avg
31.96%
5Y Avg
30.60%
Market Cap
$236.17M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$228.42M
Net Profit Margin
-29747.89%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$228.27M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $232.50M | -155582.08% | -11329.47% | -10979.33% | -3543.07% |
| MacroGenics, Inc. (MGNX)vs › | $233.28M | -8.70% | -47.52% | -47.68% | -98.44% |
| BioAge Labs Inc. (BIOA)vs › | $233.62M | -912.25% | -448.06% | -224.03% | -224.03% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $234.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | -5.14% | 33.66% | 36.64% | 40.60% |
| Utah Medical Products, Inc. (UTMD)vs › | $234.98M | 29.04% | 31.61% | 31.96% | 30.60% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.17M | -13.54% | -22.79% | -26.12% | -61.39% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $228.42M | -29747.89% | 0.00% | 0.00% | 0.00% |
| Biodesix, Inc. (BDSX)vs › | $228.27M | -26.97% | -50.02% | -94.39% | -87.59% |
| Invivyd, Inc. (IVVD)vs › | $236.69M | -183.90% | -383.83% | -191.92% | -127.94% |
Operating Margin
-164525.5%
Net Profit Margin
-155582.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 31364.81% |
| 2025-09-30 | -51452.32% |
| 2025-06-30 | -36559.83% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 1208456.74% |
| 2024-09-30 | -14092.87% |
| 2024-06-30 | -217803.07% |
| 2024-03-31 | -26798.11% |
| 2023-12-31 | -696857.22% |
| 2023-09-30 | -12255.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
